Skip to main content
SINSIN PHARMACEUTICAL Co., LTD. logo

SINSIN PHARMACEUTICAL Co., LTD. — Investor Relations & Filings

Ticker · 002800 ISIN · KR7002800001 KO Manufacturing
Open in API
Filings indexed 175 across all filing types
Latest filing 2022-12-23 Major Shareholding Noti…
Country KR South Korea
Listing KO 002800

About SINSIN PHARMACEUTICAL Co., LTD.

https://sinsin2002.tradekorea.com/

Sinsin Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter (OTC) medicines for external use. The company's core product portfolio centers on topical anti-inflammatory and analgesic drugs, including its widely recognized brand of pain relief patches, "SINSIN PAS," alongside various sprays and lotions. The company also produces a diverse range of consumer healthcare items such as mosquito repellents, wound care products like surgical plasters and healing bands, anti-mycotic treatments, and other dermatological preparations for both domestic and overseas markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership of major shareholders and special related parties, including changes in representative reporting status due to inheritance. This falls under the category of Major Shareholding Notification (MRQ).
2022-12-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Lee Byungki) of Sinsin Pharmaceutical Co., Ltd. This type of filing, which details changes in share ownership by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided taxonomy.
2022-12-23 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Shinshin Pharmaceutical) announcing a change in the 'Largest Shareholder' (최대주주변경). It details the transition of share ownership due to inheritance following the passing of the previous largest shareholder. This type of disclosure regarding significant changes in ownership structure and control is classified as a Major Shareholding Notification (MRQ) in many jurisdictions, but given the specific nature of the change in control and the regulatory filing format, it fits best under the 'Major Shareholding Notification' category as it tracks the shift in significant ownership thresholds and identity.
2022-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the upcoming meeting's administrative requirements. As it is a standard regulatory announcement that does not fit into specific categories like dividend declarations or proxy solicitations, it is classified as a general regulatory filing.
2022-12-15 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Sinsin Pharmaceutical Co., Ltd. for the period ending September 30, 2022. It contains detailed financial statements, management discussion, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Sul Geundong) of Sinsin Pharmaceutical. This is a standard regulatory filing for insider trading/director dealings, which falls under the 'Director's Dealing' category.
2022-09-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.